The Probiota 2021 Digital Summit ran over three consecutive week days (9, 10, 11 February) with a broadcast each day lasting for two hours. The topics included European Regulatory Opportunities for the Next Decade, Beyond the Gut, and Pre & Probiotics Futures. The digital summit is now available on-demand for FREE . Click on the button below to watch the summit:
The Three Category Focused Events
Tuesday, February 9, 2021 - 14.00 to 16.00 CET
European regulatory opportunities for the next decade
With Spain’s landmark decision to allow the use of the term "probiotic" and other Member States charting their domestic courses on the issue, there could be a sea-change occurring across the EU… and that’s even before you explore the uncharted waters of a post-Brexit UK.
The session brought together experts from across Europe to discuss the changing landscape, the lessons learned so far, and what comes next for probiotics and prebiotics from a regulatory perspective across the European Union.
Wednesday, February 10, 2021 - 14.00 to 16.00 CET
Beyond the Gut
As technological challenges are being overcome and research tools are advancing in capabilities, probiotics and prebiotics are increasingly moving beyond digestive health and into other research sectors.
With science uncovering more pre- and probiotic health benefits, the potential is there with applications to skin and ocular health as well as fertility/women’s health looking likely as this session looks to discuss these areas that are proving ripe for discovery and innovation.
Thursday, February 11, 2021 - 14.00 to 16.00 CET
Pre & Probiotics Futures
Our final day discussed the direction pre-and probiotic research could take as we look to the future, discussing how companies might continue to innovate in this field, and how to effectively communicate ground-breaking research and new found benefits within the boundaries of regulations.
Key areas of discussion included the popularity of personalised nutrition and health tech, the increased awareness of immunity created by COVID-19, and how recent changes in legislation could impact the EU market.